Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Tamir Miloh

Pediatric Transplant Hepatology Miami, FL Medical Doctor

NPI 1184823718 CMS profile 682068

1611 Nw 12Th Ave, Miami, FL 33136

Open in the dashboard

General payments

$60,191

66 records reported · program years 2019–2022

Research payments

$5,367

Paid to them · 3 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$73,117 paid to institutions, not to them · program years 2019–2022

Through program year 2022, Tamir Miloh of Miami, FL is reported in the CMS Open Payments database as having received $60,191 across 66 general payments and $5,367 in research payments paid to them. Separately, studies naming them as principal investigator received $73,117 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $13,200 1
2021 General $12,428 14
2020 General $13,812 18
2019 General $20,750 33
2019 Research $5,367 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tamir Miloh
  • Pediatric Transplant Hepatology median
  • Middle half of Pediatric Transplant Hepatology
  • National median

In program year 2025, general payments to Tamir Miloh were reported at $0. Among 32 Pediatric Transplant Hepatology profiles paid that year, the median was $425 and the middle half received between $120 and $5,010.

Show as a table
Year Tamir Miloh Pediatric Transplant Hepatology median Middle half National median
2019 $20,750 $116 $20–$3,335 $163
2020 $13,812 — — $114
2021 $12,428 — — $132
2022 $13,200 $2,141 $98–$13,200 $149
2023 $0 $2,469 $113–$13,954 $160
2024 $0 $3,425 $336–$18,765 $164
2025 $0 $425 $120–$5,010 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Alexion Pharmaceuticals, Inc. $40,508 49 payments
  2. Mirum Pharmaceuticals, Inc. $13,200 1 payment
  3. Intercept Pharmaceuticals, Inc. $5,920 7 payments
  4. Alnylam Pharmaceuticals Inc. $467 1 payment
  5. Retrophin, Inc. $96 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,500 11 payments
  2. Consulting Fee $18,667 3 payments
  3. Travel and Lodging $7,041 23 payments
  4. Honoraria $3,750 1 payment
  5. Food and Beverage $1,137 20 payments
  6. Education $96 8 payments
Products named General payments · program years 2019–2022
  1. Kanuma $6,058 15 payments
  2. Strensiq $5,525 2 payments
  3. Cholbam $96 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Alexion Pharmaceuticals, Inc. $5,367 3 payments

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Transplant Hepatology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record